The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
Grant Title | CFDA | Funding Number |
Biomedical Research Facilities (C06 Clinical Trial Not Allowed) |
93.352 |
PAR-23-306 |
Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional) |
93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399 |
PAR-23-308 |
Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R01 Clinical Trial Not Allowed) |
93.279 |
RFA-DA-25-011 |
Limited Competition: Development and Renovation of Facilities for Expanding the Breeding Capacity of Specific Pathogen Free Non-Human Primates to Support HIV/AIDS-related Research (C06 Clinical Trial Not Allowed) |
93.352 |
PAR-24-033 |
National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32) |
93.859 |
PAR-23-228 |
Human Tumor Atlas (HTA) Research Centers (U01 Clinical Trial Not Allowed) |
93.393, 93.394, 93.395, 93.396, 93.399 |
RFA-CA-23-039 |
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional) |
93.279 |
RFA-DA-25-059 |
R25 for Short Courses on Techniques for Measuring Intimate Partner Violence (IPV) in Different Populations (R25 Clinical Trial Not Allowed) |
93.313, 93.361, 93.865 |
RFA-OD-24-002 |
Single Source: Human Tumor Atlas Network Data Coordinating Center (HTAN-DCC; U24 Clinical Trial Not Allowed) |
93.393, 93.394, 93.395, 93.396, 93.399 |
RFA-CA-23-041 |
Pre-Cancer Atlas (PCA) Research Centers (U01 Clinical Trial Not Allowed) |
93.393, 93.394, 93.395, 93.396, 93.399 |
RFA-CA-23-040 |
Career Enhancement Award to Advance the Study of Intimate Partner Violence (IPV) in the Context of Maternal Morbidity and Mortality Research (K18 Clinical Trial Not Allowed) |
93.313, 93.361, 93.865 |
RFA-OD-24-001 |
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed) |
93.855 |
PAR-24-037 |
Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award to Promote Diversity (F99/K00 - Clinical Trial Not Allowed) |
93.213, 93.286, 93.859, 93.867, 93.879 |
PAR-23-222 |
Advancing Research Careers (ARC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed) |
93.213, 93.859 |
PAR-23-221 |
Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) |
93.398 |
PAR-23-276 |
Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Basic Experimental Studies with Humans Required) |
93.279 |
RFA-DA-24-032 |
Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Clinical Trial Optional) |
93.279 |
RFA-DA-24-033 |
Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Basic Experimental Studies with Humans Required) |
93.847 |
RFA-DA-24-034 |
Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) |
93.279 |
RFA-DA-25-047 |
Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) |
93.279 |
RFA-DA-25-048 |
Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Clinical Trial Optional) |
93.279 |
RFA-DA-24-031 |
NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed) |
93.121 |
RFA-DE-24-006 |
Mechanistic Studies of the Effects of Psychosocial Stress on Complex Morbidity Involving SUD, Psychiatric Disorders, and HIV (R01 Basic Experimental Studies with Humans (BESH) Required) |
93.279 |
RFA-DA-24-006 |
Mechanistic Studies of the Effects of Psychosocial Stress on Complex Morbidity Involving SUD, Psychiatric Disorders, and HIV (R01 Clinical Trials Optional) |
93.279 |
RFA-DA-24-005 |
Fc-Dependent Mechanisms of Antibody-Mediated Killing (R01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-23-054 |
Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional) |
93.173, 93.273, 93.286, 93.307, 93.361, 93.399, 93.846, 93.853, 93.865, 93.866, 93.867 |
PAR-23-309 |
Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional) |
93.846, 93.853, 93.865 |
RFA-NS-23-032 |
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed) |
93.172 |
PAR-23-302 |
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed) |
93.172 |
PAR-23-301 |
Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required) |
93.307, 93.313 |
RFA-MD-24-003 |
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required) |
93.121, 93.395 |
PAR-23-284 |
HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R61/R33 Clinical Trial Optional) |
93.213, 93.279, 93.866 |
RFA-DA-24-066 |
HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R01 Clinical Trial Optional) |
93.213, 93.279, 93.866 |
RFA-DA-24-067 |
Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed) |
93.398 |
PAR-23-278 |
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R21 Clinical Trial Not Allowed) |
93.279 |
RFA-DA-25-017 |
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R01 Clinical Trial Not Allowed) |
93.279 |
RFA-DA-25-016 |
Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) |
93.398 |
PAR-23-277 |
Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R01 Clinical Trial Optional) |
93.242, 93.310, 93.313, 93.865 |
RFA-MH-24-330 |
Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01 Clinical Trial Not Allowed) |
93.242, 93.855, 93.865 |
PAR-23-297 |
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-EY-23-001 |
Search Results 361-400 of 14606 [Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |